Clinipace Blog

New eBook: Cancer Drug Development Using Molecular Pathology

Considerable resources are expended for the prevention and treatment of cancer. In fact, it’s the second most common cause of death in the United States, and accounts for $216.6 billion in costs annually. However, most drugs are prescribed based on histology and not... read more

Clinipace Attending CED 2015 Life Science Conference

Clinipace will be attending the CED Life Science Conference, the leading life science conference in the Southeast, March 3-4 in Raleigh, NC. Keep an eye out for our team members, including CEO Jeff Williams and Darcy Forman, senior director of project management.... read more

Clinipace Announces $50 Million M&A War Chest

We are thrilled to announce our company has closed a $50 million round of debt and equity financing to capitalize on a pipeline of corporate acquisitions. The financing was led by Virgo Investment Group, LLC (“Virgo”) of Redwood Shores, CA, and its investor partners,... read more
Share This